ES2044043T3 - Procedimiento para preparar n-piridinil-9h-carbazol-9-aminas. - Google Patents

Procedimiento para preparar n-piridinil-9h-carbazol-9-aminas.

Info

Publication number
ES2044043T3
ES2044043T3 ES89123612T ES89123612T ES2044043T3 ES 2044043 T3 ES2044043 T3 ES 2044043T3 ES 89123612 T ES89123612 T ES 89123612T ES 89123612 T ES89123612 T ES 89123612T ES 2044043 T3 ES2044043 T3 ES 2044043T3
Authority
ES
Spain
Prior art keywords
rent
hydrogen
halogen
piridinil
aminas
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89123612T
Other languages
English (en)
Spanish (es)
Inventor
Richard Charles Effland
Joseph Thomas Klein
Larry Davis
Gordon Edward Olsen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Hoechst Roussel Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Roussel Pharmaceuticals Inc filed Critical Hoechst Roussel Pharmaceuticals Inc
Application granted granted Critical
Publication of ES2044043T3 publication Critical patent/ES2044043T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61Halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
ES89123612T 1988-12-27 1989-12-21 Procedimiento para preparar n-piridinil-9h-carbazol-9-aminas. Expired - Lifetime ES2044043T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/289,887 US4868190A (en) 1988-12-27 1988-12-27 N-pyridinyl-9H-carbazol-9-amines

Publications (1)

Publication Number Publication Date
ES2044043T3 true ES2044043T3 (es) 1994-01-01

Family

ID=23113557

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89123612T Expired - Lifetime ES2044043T3 (es) 1988-12-27 1989-12-21 Procedimiento para preparar n-piridinil-9h-carbazol-9-aminas.

Country Status (19)

Country Link
US (1) US4868190A (en:Method)
EP (1) EP0376155B1 (en:Method)
JP (1) JPH0725749B2 (en:Method)
KR (1) KR900009596A (en:Method)
AT (1) ATE79118T1 (en:Method)
AU (1) AU623205B2 (en:Method)
CA (1) CA2006529C (en:Method)
DE (1) DE68902386T2 (en:Method)
DK (1) DK662189A (en:Method)
ES (1) ES2044043T3 (en:Method)
FI (1) FI896243A7 (en:Method)
GR (1) GR3006140T3 (en:Method)
IE (1) IE894175L (en:Method)
IL (1) IL92867A0 (en:Method)
NO (1) NO895222L (en:Method)
NZ (1) NZ231943A (en:Method)
PH (1) PH27122A (en:Method)
PT (1) PT92696A (en:Method)
ZA (1) ZA899904B (en:Method)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4916135A (en) * 1989-05-08 1990-04-10 Hoechst Roussel Pharmaceuticals Inc. N-heteroaryl-4-quinolinamines
ATE118002T1 (de) * 1989-08-02 1995-02-15 Hoechst Roussel Pharma 2,3-dihydro-1-(pyridinylamino)-indole, verfahren zu ihrer herstellung und ihre anwendung als arzneimittel.
US5179099A (en) * 1989-08-02 1993-01-12 Hoechst-Roussel Pharmaceuticals Incorporated 2,3-dihydro-1-(pyridinylamino)-indoles
US4994472A (en) * 1989-08-02 1991-02-19 Hoechst-Roussel Pharmaceuticals Incorporated 1-(pyridinylamino)-2-pyrrolidinones as pain relievers
US4983608A (en) * 1989-09-05 1991-01-08 Hoechst-Roussell Pharmaceuticals, Inc. N-substituted-4-pyrimidinamines and pyrimidinediamines
KR100445629B1 (ko) * 1995-07-27 2004-10-14 아벤티스 파마슈티칼스 인크. 비치환및치환된n-(피롤-1-일)피리딘아민의항경련제로서의용도
US5776955A (en) * 1995-07-27 1998-07-07 Hoechst Marion Roussel, Inc. Use of unsubstituted and substituted n-(pyrrol-1-yl)pyridinamines as anticonvulsant agents
ZA989365B (en) * 1997-10-15 1999-04-15 Boehringer Mannheim Pharm Corp Preparation for treating alzheimer's disease
EP1305082B1 (en) * 2000-07-21 2004-05-26 Ortho-McNeil Pharmaceutical, Inc. Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH475982A (de) * 1966-11-16 1969-07-31 Wander Ag Dr A Verfahren zur Herstellung von Carbazolderivaten
EP0073849A1 (en) * 1981-09-03 1983-03-16 Schering Corporation Novel phenyl-1,2,3,4-tetrahydrocarbazoles, their preparation and pharmaceutical compositions containing them
US4792562A (en) * 1985-12-04 1988-12-20 Hoechst-Roussel Pharmaceuticals, Inc. N-(pyrrol-1-yl)pyridinamines having memory enhancing activity
US4752610A (en) * 1985-12-04 1988-06-21 Hoechst-Roussel Pharmaceuticals Inc. N-(pyrrol-1-yl)pyridinamines having memory enhancing properties
ATE115143T1 (de) * 1987-04-24 1994-12-15 Hoechst Roussel Pharma N-(pyridinyl)-1h-indol-1-amine, verfahren zu deren herstellung und ihre verwendung als arzneimittel.
US4806554A (en) * 1988-01-11 1989-02-21 Hoechst-Roussel Pharmaceuticals, Inc. Pyrazol and indazolpyridinamines
US4916135A (en) * 1989-05-08 1990-04-10 Hoechst Roussel Pharmaceuticals Inc. N-heteroaryl-4-quinolinamines
ATE118002T1 (de) * 1989-08-02 1995-02-15 Hoechst Roussel Pharma 2,3-dihydro-1-(pyridinylamino)-indole, verfahren zu ihrer herstellung und ihre anwendung als arzneimittel.
US5006537A (en) * 1989-08-02 1991-04-09 Hoechst-Roussel Pharmaceuticals, Inc. 1,3-dihydro-1-(pyridinylamino)-2H-indol-2-ones

Also Published As

Publication number Publication date
JPH02247173A (ja) 1990-10-02
NO895222D0 (no) 1989-12-22
ZA899904B (en) 1991-02-27
FI896243A7 (fi) 1990-06-28
AU4720389A (en) 1990-07-05
DK662189D0 (da) 1989-12-22
PH27122A (en) 1993-03-16
DE68902386T2 (de) 1993-02-11
KR900009596A (ko) 1990-07-05
NZ231943A (en) 1992-06-25
DK662189A (da) 1990-06-28
CA2006529A1 (en) 1990-06-27
IE894175L (en) 1990-06-27
GR3006140T3 (en:Method) 1993-06-21
NO895222L (no) 1990-06-28
FI896243A0 (fi) 1989-12-22
ATE79118T1 (de) 1992-08-15
JPH0725749B2 (ja) 1995-03-22
AU623205B2 (en) 1992-05-07
EP0376155B1 (en) 1992-08-05
US4868190A (en) 1989-09-19
CA2006529C (en) 1999-08-10
PT92696A (pt) 1990-06-29
IL92867A0 (en) 1990-09-17
EP0376155A1 (en) 1990-07-04
DE68902386D1 (de) 1992-09-10

Similar Documents

Publication Publication Date Title
ES8101077A1 (es) Procedimiento para preparar acidos 3-cefem-4-carboxilicos sustituidos en la posicion 7
ES8101628A1 (es) Procedimiento para la estabilizacion de materias organicas polimeras.
ES2044043T3 (es) Procedimiento para preparar n-piridinil-9h-carbazol-9-aminas.
ES2073246T3 (es) Derivados de pirazina.
ES8200679A1 (es) Un procedimiento para la preparacion de derivados de carboestirilo.
CO4700291A1 (es) Compuestos quimicos
ES2085940T3 (es) 4-amino-3-piridinoles sustituidos, un procedimiento para su preparacion y su uso como medicamentos.
ES369571A1 (es) Procedimiento para la preparacion de 1,3,4-tiadiazolil-(2)-ureas..
ES439648A1 (es) Un procedimiento para la preparacion de una composicion de blanqueo, que contiene un aducto sulfato sodico-peroxido de hidrogeno.
ES8104245A1 (es) Procedimiento para la preparacion de derivados de bencimida-zol
ES8502440A1 (es) Procedimiento para preparar acepinoindoles.
ES8502086A1 (es) Procedimiento para la obtencion de derivados de feniletilamina
ES422906A1 (es) Un procedimiento para preparar nuevos derivados de 2-amino-indano.
ES8705357A1 (es) Procedimiento para preparar nuevos derivados del 1,1,2,2-tetrametil-1,2-bis-(2-fluoro-4-hidroxi-fenil)-etano
ES2101738T3 (es) Tintes de benzoxacina.
ES462890A1 (es) Procedimiento para la preparacion de 1-(n-acil-carbamoil)-2-cianazi-ridinas con efecto cancerostatico y estimulador de inmunidad.
ES292885A1 (es) Procedimiento para preparar 4-desdimetilamino-4-sustituído-amino-6-desmetiltetraciclinas
ES2085323T3 (es) Compuestos de espiro-indolin-oxazina con caracteristicas fotocromaticas y fotosensibilizantes y el procedimiento para su preparacion.
GB872997A (en) Substituted ún-aminoalkoxy-acyl benzenes and processes for their manufacture
ES430676A1 (es) Procedimiento para la preparacion de 1,2,4-tiadiazolo- (2,3-a) bencimidazoles-2-sustituidos.
ES2036600T3 (es) Procedimiento para preparar 1-(3-(2-dialquilaminoetoxi)-2-tienil)-3-fenil-1-propanonas.
MX3116E (es) Procedimiento para la preparacion de derivados de 2 - amino - acetamido - alfa - fenil bencil iden amino alcanol
ES2083401T3 (es) Procedimiento para la preparacion de penemas.
ES406767A1 (es) Procedimiento para la preparacion de nuevos derivados de indol.
ES431032A1 (es) Procedimiento para preparar nuevas composiciones inyectablesde halometanosulfonamida.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 376155

Country of ref document: ES